These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2418952)
1. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Dickson RB; Bates SE; McManaway ME; Lippman ME Cancer Res; 1986 Apr; 46(4 Pt 1):1707-13. PubMed ID: 2418952 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines. Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542 [TBL] [Abstract][Full Text] [Related]
4. Production of transforming growth factors by human colon cancer lines. Coffey RJ; Shipley GD; Moses HL Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610 [TBL] [Abstract][Full Text] [Related]
5. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Herman ME; Katzenellenbogen BS Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416 [TBL] [Abstract][Full Text] [Related]
6. Presence of transforming growth factors in human breast cancer cells. Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663 [TBL] [Abstract][Full Text] [Related]
7. Growth factor production by human colon carcinoma cell lines. Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Arteaga CL; Carty-Dugger T; Moses HL; Hurd SD; Pietenpol JA Cell Growth Differ; 1993 Mar; 4(3):193-201. PubMed ID: 8466857 [TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Bates SE; Davidson NE; Valverius EM; Freter CE; Dickson RB; Tam JP; Kudlow JE; Lippman ME; Salomon DS Mol Endocrinol; 1988 Jun; 2(6):543-55. PubMed ID: 3047554 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281 [TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells. Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257 [TBL] [Abstract][Full Text] [Related]
12. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells. Davidson NE; Prestigiacomo LJ; Hahm HA Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822 [TBL] [Abstract][Full Text] [Related]
13. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Karey KP; Sirbasku DA Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739 [TBL] [Abstract][Full Text] [Related]
14. Purification and biological properties of type beta transforming growth factor from mouse transformed cells. Fernandez-Pol JA; Klos DJ; Grant GA Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Arrick BA; Korc M; Derynck R Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070 [TBL] [Abstract][Full Text] [Related]
16. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A. Yamada Y; Serrero G J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein. Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Zugmaier G; Paik S; Wilding G; Knabbe C; Bano M; Lupu R; Deschauer B; Simpson S; Dickson RB; Lippman M Cancer Res; 1991 Jul; 51(13):3590-4. PubMed ID: 2054795 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Liu C; Tsao MS; Grisham JW Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400 [TBL] [Abstract][Full Text] [Related]
20. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]